DNA methylation in cell differentiation and reprogramming: An emerging systematic view

Regenerative Medicine

Volumn 5, Issue 4, 2010, Pages 531-544

  Huang, Kevin ^a   Fan, Guoping ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

5 aza cytidine; differentiation; DNA methylation; embryonic stem cell; ESC; induced pluripotent stem cells; iPS; pluripotency; reprogramming

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ADIPOSE TISSUE; CELL DIFFERENTIATION; CELL RENEWAL; CELL REPROGRAMMING; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; EMBRYONIC STEM CELL; EPIGENETICS; EXON; GENE SILENCING; GENOME; GERM CELL; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNOPRECIPITATION; INTRON; MEDICAL RESEARCH; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; PROMOTER REGION; REGENERATIVE MEDICINE; REVIEW; SOMATIC CELL; TRANSCRIPTION INITIATION SITE;

ADULT; CELL DIFFERENTIATION; DNA METHYLATION; EMBRYONIC STEM CELLS; HUMANS; NUCLEAR REPROGRAMMING;

EID: 77954811475     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.10.35     Document Type: Review

References (116)

1. Wu C, Morris JR: Genes, genetics, and epigenetics: a correspondence. Science 293(5532), 1103-1105 (2001).
2. Reik W: Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447(7143), 425-432 (2007).
3. Miranda TB, Jones PA: DNA methylation: the nuts and bolts of repression. J. Cell. Physiol. 213(2), 384-390 (2007).
4. Okano M, Bell DW, Haber DA, Li E: DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99(3), 247-257 (1999).
5. Li E, Bestor TH, Jaenisch R: Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69(6), 915-926 (1992).
6. Leonhardt H, Page AW, Weier HU, Bestor TH: A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell 71(5), 865-873 (1992).
7. Liu Y, Oakeley EJ, Sun L, Jost JP: Multiple domains are involved in the targeting of the mouse DNA methyltransferase to the DNA replication foci. Nucleic Acids Res. 26(4), 1038-1045 (1998).
8. Kim GD, Ni J, Kelesoglu N, Roberts RJ, Pradhan S: Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J. 21(15), 4183-4195 (2002).
9. Chen T, Ueda Y, Dodge JE, Wang Z, Li E: Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b. Mol. Cell. Biol. 23(16), 5594-5605 (2003).
10. Hattori N, Abe T, Suzuki M, et al.: Preference of DNA methyltransferases for CpG islands in mouse embryonic stem cells. Genome Res. 14(9), 1733-1740 (2004).
11. Feng J, Zhou Y, Campbell SL, et al.: Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat. Neurosci. 13(4), 423-430 (2010).
12. Hochedlinger K, Plath K: Epigenetic reprogramming and induced pluripotency. Development 136(4), 509-523 (2009).
13. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4), 663-676 (2006).
14. Takahashi K, Tanabe K, Ohnuki M, et al.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5), 861-872 (2007).
15. Yu J, Vodyanik MA, Smuga-Otto K, et al.: Induced pluripotent stem cell lines derived from human somatic cells. Science (New York) 318(5858), 1917-1920 (2007).
16. Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3(6), 415-428 (2002).
17. Gardiner-Garden M, Frommer M: Cpg islands in vertebrate genomes. J. Mol. Biol. 196(2), 261-282 (1987).
18. Takai D, Jones PA: Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl Acad. Sci. USA 99(6), 3740-3745 (2002).
19. Meissner A, Mikkelsen TS, Gu H, et al.: Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454(7205), 766-770 (2008).
20. Mohn F, Weber M, Rebhan M, et al.: Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol. Cell 30(6), 755-766 (2008).
21. Fouse SD, Shen Y, Pellegrini M, et al.: Promoter Cpg methylation contributes to ES cell gene regulation in parallel with Oct4/ Nanog, PcG complex, and histone H3 K4/ K27 trimethylation. Cell Stem Cell 2(2), 160-169 (2008).
22. Weber M, Hellmann I, Stadler MB, et al.: Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet. 39(4), 457-466 (2007).
23. Ball MP, Li JB, Gao Y, et al.: Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat. Biotechnol. 27(4), 361-368 (2009).
24. Saxonov S, Berg P, Brutlag DL: A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc. Natl Acad. Sci. USA 103(5), 1412-1417 (2006).
25. Mikkelsen TS, Ku M, Jaffe DB, et al.: Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448(7153), 553-560 (2007).
26. Suzuki MM, Bird A: DNA methylation landscapes: Provocative insights from epigenomics. Nat. Rev. 9(6), 465-476 (2008).
27. Hellman A, Chess A: Gene body-specific methylation on the active X chromosome. Science 315(5815), 1141-1143 (2007).
28. Deng J, Shoemaker R, Xie B, et al.: Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat. Biotechnol. 27(4), 353-360 (2009).
29. Lister R, Pelizzola M, Dowen RH, et al.: Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462(7271), 315-322 (2009).
30. Laurent L, Wong E, Li G, et al.: Dynamic changes in the human methylome during differentiation. Genome Res. 20(3), 320-331 (2010).
31. Straussman R, Nejman D, Roberts D, et al.: Developmental programming of CpG island methylation profiles in the human genome. Nat. Struct. Mol. Biol. 16(5), 564-571 (2009).
32. Xu J, Watts JA, Pope SD, et al.: Transcriptional competence and the active marking of tissue-specific enhancers by defined transcription factors in embryonic and induced pluripotent stem cells. Genes Dev. 23(24), 2824-2838 (2009).
33. Ooi SK, Qiu C, Bernstein E, et al.: Dnmt3l connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 448(7154), 714-717 (2007).
34. Oswald J, Engemann S, Lane N, et al.: Active demethylation of the paternal genome in the mouse zygote. Curr. Biol. 10(8), 475-478 (2000).
35. Mayer W, Niveleau A, Walter J, Fundele R, Haaf T: Demethylation of the zygotic paternal genome. Nature 403(6769), 501-502 (2000).
36. Rougier N, Bourchis D, Gomes DM, et al.: Chromosome methylation patterns during mammalian preimplantation development. Genes Dev. 12(14), 2108-2113 (1998).
37. Santos F, Hendrich B, Reik W, Dean W: Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev. Biol. 241(1), 172-182 (2002).
38. Okada Y, Yamagata K, Hong K, Wakayama T, Zhang Y: A role for the elongator complex in zygotic paternal genome demethylation. Nature 463(7280), 554-558 (2010).
39. Carlson LL, Page AW, Bestor TH: Properties and localization of DNA methyltransferase in preimplantation mouse embryos: implications for genomic imprinting. Genes Dev. 6(12B), 2536-2541 (1992).
40. Cardoso MC, Leonhardt H: DNA methyltransferase is actively retained in the cytoplasm during early development. J. Cell Biol. 147(1), 25-32 (1999).
41. Mayer W, Fundele R, Haaf T: Spatial separation of parental genomes during mouse interspecific (Mus musculus x M. spretus) spermiogenesis. Chromosome Res. 8(6), 555-558 (2000).
42. Kwon GS, Viotti M, Hadjantonakis AK: The endoderm of the mouse embryo arises by dynamic widespread intercalation of embryonic and extraembryonic lineages. Dev. Cell 15(4), 509-520 (2008).
43. Ng RK, Dean W, Dawson C, et al.: Epigenetic restriction of embryonic cell lineage fate by methylation of Elf5. Nat. Cell. Biol. 10(11), 1280-1290 (2008).
44. Donnison M, Beaton A, Davey HW, Broadhurst R, Lhuillier P, Pfeffer PL: Loss of the extraembryonic ectoderm in Elf5 mutants leads to defects in embryonic patterning. Development 132(10), 2299-2308 (2005).
45. Hirasawa R, Sasaki H: Dynamic transition of Dnmt3b expression in mouse pre- and early post-implantation embryos. Gene Expr. Patterns 9(1), 27-30 (2009).
46. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al.: Embryonic stem cell lines derived from human blastocysts. Science 282(5391), 1145-1147 (1998).
47. Tucker KL, Beard C, Dausmann J, et al.: Germ-line passage is required for establishment of methylation and expression patterns of imprinted but not of nonimprinted genes. Genes Dev. 10(8), 1008-1020 (1996).
48. Tsumura A, Hayakawa T, Kumaki Y, et al.: Maintenance of self-renewal ability of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3b. Genes Cells 11(7), 805-814 (2006).
49. Jackson M, Krassowska A, Gilbert N, et al.: Severe global DNA hypomethylation blocks differentiation and induces histone hyperacetylation in embryonic stem cells. Mol. Cell. Biol. 24(20), 8862-8871 (2004).
50. Carlone DL, Lee JH, Young SR, et al.: Reduced genomic cytosine methylation and defective cellular differentiation in embryonic stem cells lacking CpG binding protein. Mol. Cell. Biol. 25(12), 4881-4891 (2005).
51. Farthing CR, Ficz G, Ng RK, et al.: Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes. PLoS Genet. 4(6), e1000116 (2008).
52. Brandeis M, Frank D, Keshet I, et al.: Sp1 elements protect a CpG island from de novo methylation. Nature 371(6496), 435-438 (1994).
53. Gidekel S, Bergman Y: A unique developmental pattern of Oct-3/4 DNA methylation is controlled by a cis-demodification element. J. Biol. Chem. 277(37), 34521-34530 (2002).
54. Ramsahoye BH, Biniszkiewicz D, Lyko F, Clark V, Bird AP, Jaenisch R: Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc. Natl Acad. Sci. USA 97(10), 5237-5242 (2000).
55. Gowher H, Jeltsch A: Enzymatic properties of recombinant Dnmt3a DNA methyltransferase from mouse: the enzyme modifies DNA in a non-processive manner and also methylates non-CpG [correction of non-CpA] sites. J. Mol. Biol. 309(5), 1201-1208 (2001). (Pubitemid 32623318)
56. Dodge JE, Ramsahoye BH, Wo ZG, Okano M, Li E: De novo methylation of MMLV provirus in embryonic stem cells: CpG versus non-CpG methylation. Gene 289(1-2), 41-48 (2002).
57. White GP, Watt PM, Holt BJ, Holt PG: Differential patterns of methylation of the IFN-g promoter at CpG and non-CpG sites underlie differences in IFN-g gene expression between human neonatal and adult CD45ro- T cells. J. Immunol. 168(6), 2820-2827 (2002).
58. Suetake I, Miyazaki J, Murakami C, Takeshima H, Tajima S: Distinct enzymatic properties of recombinant mouse DNA methyltransferases Dnmt3a and Dnmt3b. J. Biochem. 133(6), 737-744 (2003).
59. Barres R, Osler ME, Yan J, et al.: Non-CpG methylation of the pgc-1a promoter through Dnmt3b controls mitochondrial density. Cell Metab. 10(3), 189-198 (2009).
60. Biniszkiewicz D, Gribnau J, Ramsahoye B, et al.: Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality. Mol. Cell. Biol. 22(7), 2124-2135 (2002).
61. Broske AM, Vockentanz L, Kharazi S, et al.: DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat. Genet. 41(11), 1207-1215 (2009).
62. Trowbridge JJ, Snow JW, Kim J, Orkin SH: DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells. Cell Stem Cell 5(4), 442-449 (2009).
63. Takizawa T, Nakashima K, Namihira M, et al.: DNA methylation is a critical cell-intrinsic determinant of astrocyte differentiation in the fetal brain. Dev. Cell 1(6), 749-758 (2001).
64. Fan G, Martinowich K, Chin MH, et al.: DNA methylation controls the timing of astrogliogenesis through regulation of JAK-STAT signaling. Development 132(15), 3345-3356 (2005).
65. Sen GL, Reuter JA, Webster DE, Zhu L, Khavari PA: Dnmt1 maintains progenitor function in self-renewing somatic tissue. Nature 463(7280), 563-567 (2010).
66. Pittenger MF, Mackay AM, Beck SC, et al.: Multilineage potential of adult human mesenchymal stem cells. Science 284(5411), 143-147 (1999).
67. Zuk PA, Zhu M, Mizuno H, et al.: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7(2), 211-228 (2001).
68. Boquest AC, Shahdadfar A, Fronsdal K, et al.: Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Mol. Biol. Cell 16(3), 1131-1141 (2005).
69. Noer A, Sorensen AL, Boquest AC, Collas P: Stable CpG hypomethylation of adipogenic promoters in freshly isolated, cultured, and differentiated mesenchymal stem cells from adipose tissue. Mol. Biol. Cell 17(8), 3543-3556 (2006).
70. Sorensen AL, Timoskainen S, West FD, et al.: Lineage-specific promoter DNA methylation patterns segregate adult progenitor cell types. Stem Cells Dev. (2009) (Epub ahead of print).
71. Josephson R, Ording CJ, Liu Y, et al.: Qualification of embryonal carcinoma 2102ep as a reference for human embryonic stem cell research. Stem Cells 25(2), 437-446 (2007).
72. Aranda P, Agirre X, Ballestar E, et al.: Epigenetic signatures associated with different levels of differentiation potential in human stem cells. PloS ONE 4(11), e7809 (2009).
73. Attema JL, Papathanasiou P, Forsberg EC, Xu J, Smale ST, Weissman IL: Epigenetic characterization of hematopoietic stem cell differentiation using minichip and bisulfite sequencing analysis. Proc. Natl Acad. Sci. USA 104(30), 12371-12376 (2007).
74. Xu J, Pope SD, Jazirehi AR, et al.: Pioneer factor interactions and unmethylated CpG dinucleotides mark silent tissue-specific enhancers in embryonic stem cells. Proc. Natl Acad. Sci. USA 104(30), 12377-12382 (2007).
75. Tadokoro Y, Ema H, Okano M, Li E, Nakauchi H: De novo DNA methyltransferase is essential for self-renewal, but not for differentiation, in hematopoietic stem cells. J. Exp. Med. 204(4), 715-722 (2007).
76. Temple S: Stem cell plasticity - building the brain of our dreams. Nat. Rev. Neurosci. 2(7), 513-520 (2001).
77. Shen Y, Chow J, Wang Z, Fan G: Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells. Human Mol. Genet. 15(17), 2623-2635 (2006).
78. Hemberger M, Dean W, Reik W: Epigenetic dynamics of stem cells and cell lineage commitment: digging Waddingtons canal. Nat. Rev. 10(8), 526-537 (2009).
79. Hajkova P, Ancelin K, Waldmann T, et al.: Chromatin dynamics during epigenetic reprogramming in the mouse germ line. Nature 452(7189), 877-881 (2008).
80. Popp C, Dean W, Feng S, et al.: Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature 463(7284), 1101-1105 (2010).
81. Surani MA, Durcova-Hills G, Hajkova P, Hayashi K, Tee WW: Germ line, stem cells, and epigenetic reprogramming. Cold Spring Harb. Symp. Quant. Biol. 73, 9-15 (2008).
82. Eckhardt F, Lewin J, Cortese R, et al.: DNA methylation profiling of human chromosomes 6, 20 and 22. Nat. Genet. 38(12), 1378-1385 (2006).
83. Schilling E, Rehli M: Global, comparative analysis of tissue-specific promoter CpG methylation. Genomics 90(3), 314-323 (2007).
84. Illingworth R, Kerr A, Desousa D, et al.: A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol. 6(1), e22 (2008).
85. Rakyan VK, Down TA, Thorne NP, et al.: An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res. 18(9), 1518-1529 (2008).
86. Song F, Mahmood S, Ghosh S, et al.: Tissue specific differentially methylated regions (TDMR): changes in DNA methylation during development. Genomics 93(2), 130-139 (2009).
87. Doi A, Park IH, Wen B, et al.: Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet. 41(12), 1350-1353 (2009).
88. Maherali N, Sridharan R, Xie W, et al.: Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1(1), 55-70 (2007).
89. Mikkelsen TS, Hanna J, Zhang X, et al.: Dissecting direct reprogramming through integrative genomic analysis. Nature 454(7200), 49-55 (2008).
90. Ichida JK, Blanchard J, Lam K, et al.: A small-molecule inhibitor of TGF-b signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 5(5), 491-503 (2009).
91. Zhu JK: Active DNA demethylation mediated by DNA glycosylases. Annu. Rev. Genet. 43, 143-166 (2009).
92. Ma DK, Jang MH, Guo JU, et al.: Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science 323(5917), 1074-1077 (2009).
93. Barreto G, Schafer A, Marhold J, et al.: Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature 445(7128), 671-675 (2007).
94. Morgan HD, Dean W, Coker HA, Reik W, Petersen-Mahrt SK: Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. J. Biol. Chem. 279(50), 52353-52360 (2004).
95. Jin SG, Guo C, Pfeifer GP: GADD45A does not promote DNA demethylation. PLoS Genet. 4(3), e1000013 (2008).
96. Metivier R, Gallais R, Tiffoche C, et al.: Cyclical DNA methylation of a transcriptionally active promoter. Nature 452(7183), 45-50 (2008).
97. Bhutani N, Brady JJ, Damian M, Sacco A, Corbel SY, Blau HM: Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 463(7284), 1042-1047 (2009).
98. Chin MH, Mason MJ, Xie W, et al.: Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5(1), 111-123 (2009).
99. Bibikova M, Chudin E, Wu B, et al.: Human embryonic stem cells have a unique epigenetic signature. Genome Res. 16(9), 1075-1083 (2006).
100. Allegrucci C, Wu YZ, Thurston A, et al.: Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome. Human Mol. Genet. 16(10), 1253-1268 (2007).
101. Maitra A, Arking DE, Shivapurkar N, et al.: Genomic alterations in cultured human embryonic stem cells. Nat. Genet. 37(10), 1099-1103 (2005).
102. Rugg-Gunn PJ, Ferguson-Smith AC, Pedersen RA: Epigenetic status of human embryonic stem cells. Nat. Genet. 37(6), 585-587 (2005).
103. Aasen T, Raya A, Barrero MJ, et al.: Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 26(11), 1276-1284 (2008).
104. Choi SC, Yoon J, Shim WJ, Ro YM, Lim DS: 5-azacytidine induces cardiac differentiation of p19 embryonic stem cells. Exp. Mol. Med. 36(6), 515-523 (2004).
105. Huangfu D, Osafune K, Maehr R, et al.: Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol. 26(11), 1269-1275 (2008).
106. Huangfu D, Maehr R, Guo W, et al.: Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol. 26(7), 795-797 (2008).
107. Shi Y, Desponts C, Do JT, Hahm HS, Scholer HR, Ding S: Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3(5), 568-574 (2008).
108. Shi Y, Do JT, Desponts C, Hahm HS, Scholer HR, Ding S: A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2(6), 525-528 (2008).
109. Kohyama J, Abe H, Shimazaki T, et al.: Brain from bone: efficient "meta-differentiation" of marrow stroma-derived mature osteoblasts to neurons with noggin or a demethylating agent. Differentiation 68(4-5), 235-244 (2001).
110. Woodbury D, Reynolds K, Black IB: Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis. J. Neurosci. Res. 69(6), 908-917 (2002).
111. Bibikova M, Laurent LC, Ren B, Loring JF, Fan JB: Unraveling epigenetic regulation in embryonic stem cells. Cell Stem Cell 2(2), 123-134 (2008).
112. Ramirez-Carrozzi VR, Braas D, Bhatt DM, et al.: A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 138(1), 114-128 (2009).
113. Pietersen AM, Van Lohuizen M: Stem cell regulation by polycomb repressors: postponing commitment. Curr. Opin. Cell Biol. 20(2), 201-207 (2008).
114. Tahiliani M, Koh KP, Shen Y, et al.: Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324(5929), 930-935 (2009).
115. Kriaucionis S, Heintz N: The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324(5929), 929-930 (2009).
116. Loenarz C, Schofield CJ: Expanding chemical biology of 2-oxoglutarate oxygenases. Nature Chem. Biol. 4(3), 152-156 (2008).